Morgan Stanley’s Burcon NutraScience Corporation BRCN Stock Holding History

Morgan Stanley’s Portfolio BRCN Stock Details BRCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,939	Closed	-$3K	–	8134
2022 Q2	$3K	Buy	8,939 +7,719	+633%	+$5K	﹤0.01%	7560
2022 Q1	$1K	Sell	1,220 -14,294	-92%	-$14K	﹤0.01%	7923
2021 Q4	$18K	Sell	15,514 -132,075	-89%	-$176K	﹤0.01%	7261
2021 Q3	$231K	Buy	147,589 +4,112	+3%	+$9.57K	﹤0.01%	5923
2021 Q2	$400K	Buy	+143,477	New	+$459K	﹤0.01%	5666

Other funds holding BRCN

FFG

Frisch Financial Group Melville, New York $478M AUM 16.28% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Morgan Stanley's BRCN Position: Q3 2022 in Review

Morgan Stanley sold out of Burcon NutraScience Corporation (BRCN) in Q3 2022, closing a stake of 8,939 shares — an estimated $3K sold.

Morgan Stanley first reported a position in BRCN in Q2 2021 and held it in 5 quarters. The position peaked at $400K in Q2 2021. 2 funds tracked by Wall St. Rank hold BRCN as of Q3 2022.

Morgan Stanley reported no remaining Burcon NutraScience Corporation position as of Q3 2022 after selling out during the quarter.
Morgan Stanley sold 8,939 Burcon NutraScience Corporation shares in Q3 2022, an estimated $3K.
Morgan Stanley first reported a position in Burcon NutraScience Corporation in Q2 2021 and held it in 5 quarters.
Morgan Stanley's Burcon NutraScience Corporation position peaked at $400K in Q2 2021.
2 funds tracked by Wall St. Rank held Burcon NutraScience Corporation as of Q3 2022.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.